Relitecan 40mg Injection
Marketer
Reliance Formulation Pvt Ltd
Salt Composition
Irinotecan (40mg)
Overview Relitecan 40mg Injection
Camptosar 40mg Injection is indicated for colorectal cancer. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administration is via intravenous infusion by a qualified healthcare provider. Dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include tiredness, queasiness, vomiting, debility, and alopecia. This medication can decrease blood cell counts (red and white), increasing infection risk. Report fever, sore throat, or persistent diarrhea to your doctor. Regular blood tests monitoring blood cell levels, alongside heart, liver, and uric acid levels, are essential. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, or concurrent use of anti-infective medications. Inform your healthcare team of all medications you're taking, as drug interactions are possible. This injection is contraindicated during pregnancy and lactation. Effective contraception for both partners is crucial to prevent conception during treatment.
Uses of Relitecan 40mg Injection
Colorectal cancer
Major Benefits of Relitecan 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Relitecan 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Relitecan 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Relitecan 40mg Injection works:
Topotecan 40mg Injection is a chemotherapy agent that inhibits topoisomerase I, an enzyme crucial for cancer cell DNA replication. This action impedes cancer cell proliferation, leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Relitecan 40mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Relitecan 40mg Injection is contraindicated during pregnancy due to confirmed fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Use of the 40mg Relitecan injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Use of Relitecan 40mg Injection may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of 40mg Relitecan Injection in patients with kidney impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary for this population, however, medical advice is crucial. Dialysis patients should avoid this medication.
LiverCONSULT YOUR DOCTOR
Data regarding Relitecan 40mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Relitecan 40mg Injection :
Should you forget a dose of Relitecan 40mg Injection, seek medical advice.
Facts to Know About Relitecan 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Topoisomerase inhibitor |
3,018 People bought this recently